LEA KELLY: Open Payments
NPI 1790295285 · PROVIDENCE, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,513 in 72 payments from 13 companies in 2025. Trend: 2023 $1,293 · 2024 $1,501 · 2025 $1,513
Food & beverage: $1,513
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 14 | $323 |
| ABBVIE INC. | 22 | $296 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $222 |
| Janssen Biotech, Inc. | 5 | $132 |
| Braintree Laboratories, Inc. | 5 | $113 |
| Gilead Sciences, Inc. | 4 | $103 |
| Phathom Pharmaceuticals, Inc. | 3 | $74 |
| Fresenius Kabi USA, LLC | 3 | $61 |
| PFIZER INC. | 3 | $50 |
| Ardelyx, Inc. | 2 | $49 |
Products named: XIFAXAN, ENTYVIO, TREMFYA, SKYRIZI, VOQUEZNA, LINZESS, RINVOQ, SUFLAVE.
Industry payments across RI — which companies pay providers there.
